Chemours Co is trading 4.4% up at $21.20 as the stock extends a multi-day recovery following a favorable U.S. federal appeals court decision.
- The court vacated a preliminary injunction on June 8 that had previously halted the company’s business activities, removing a major legal hurdle.
- Today’s strength continues a rebound that began after the ruling, helping shares retrace a significant portion of last week’s sharp declines.
- The move signals improving investor sentiment as the company moves past recent operational uncertainty.